Phase 3 N=592 Study Assessing Double-masked Uveitis Treatment
Uveitis; Posterior, Disorder
Primary: The Primary Endpoint, VH 0 Response, Was Defined as Having a VH Score of 0 at Month 5 — 28; 44; 27 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=66 Comparing OTC Acne Treatment to Prescription Regimen
Acne Vulgaris
Primary: Treatment Tolerability Assessment: Erythema — 0.3; 0.4; 0.6; 0.4 score on a scale
N/A N=248 Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially Available Pen Needle
Diabetes
Primary: Overall User Preference -Combined Groups — 17.5 mm
Phase 4 N=12,000 A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
Cardiovascular Disease · High Cardiovascular Risk · Obesity
Primary: Time From Randomization to First Occurrence of Major Adverse Cardiovascular Events (MACE) at Interim Analysis — NA; NA days — p=0.0001
N/A N=16 Mobile Tablet Education to Advance Caregiver Health
Dementia
Primary: Change From Baseline Zarit Burden Interview (ZBI) at 4 Months — -2.25; 0.80 score on a scale
N/A N=338 A Prospective Study of Airless Tubing in an Inpatient Acute Hemodialysis Unit in Hospitalized Patients
End Stage Renal Failure on Dialysis · Complication of Dialysis · Blood Coagulation Disorders
Primary: Clotting of Extracorporeal Dialysis Circuit — 30; 33 Clotting events — p=0.79
N/A N=15 Effect of Two Toothpastes on Bacteria in Saliva
Oral Health
Primary: Change From Baseline in Area Under the Curve Between 0 and 2 Hours (AUC [0-2] Hours) for Total Viable Counts (TVCs) of Bacteria in Saliva Using Traditional Plating…
N/A N=516 PCORI-CER-1306-03385 Informed Decisions About Lung Cancer Screening
Lung Cancer · Smoking Cessation · Tobacco Use Cessation
Primary: Mean Value: Preparation for Decision Making© Scale — 79.4; 69.4 units on a scale
N/A N=134 PTSD (PostTraumatic Stress Disorder) Services for Veterans With SMI (Severe Mental Illness)
Post Traumatic Stress Disorder · Schizophrenia · Schizoaffective Disorder
Primary: Posttraumatic Stress Disorder (PTSD) Checklist (PCL) — 66.94; 66.33; 51.20; 60.60 score on a scale
Phase 3 N=369 A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Neoplasms, Breast
Primary: Progression Free Survival (PFS) Events in Lapatinib + Trastuzumab + Aromatase Inhibitor (AI) vs. Trastuzumab + Aromatase Inhibitor (AI) — 62; 75; 7; 3 Participants…
N/A N=60 Music Therapy in Sickle Cell Pain Mixed Methods Study
Sickle Cell Disease
Primary: Change (Post - Pre) From Baseline in Visual Analog Scale of Pain Intensity (VASPI) of Memorial Pain Assessment Card — -1.92; -1.92; -1.19 score on a scale
Phase 1 N=29 Extended Administration of Polyethylene Glycol (PEG) Interferon Alfa-2b in Participants With Solid Tumors (C/I97-349/MK-4031-009)
Neoplasms
Primary: Number of Participants Who Experienced an Adverse Event — 1; 2; 1; 2 Participants
N/A N=95 Sidus Stem-Free Shoulder IDE Study
Osteoarthritis · Posttraumatic Arthrosis · Rheumatoid Arthritis
Primary: Pain and Function as Measured by the American Society of Shoulder and Elbow Surgeons Questionnaire — 89.4; 0.7 score on a scale
N/A N=82 Role of Neutrophil Activation
Patients Requiring Endotracheal Intubation
Primary: Neutrophil Cell Counts in Tracheal Lavages — 112.02; 26.98; 61.72; 27.63 neutrophil/high powered field — p=<0.05
Phase 4 N=2,425 A 24-week Study to Compare Umeclidinium/Vilanterol (UMEC/VI), UMEC and Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Pulmonary Disease, Chronic Obstructive
Primary: Change From Baseline in Trough Forced Expiratory Volume in One Second (FEV1) at Week 24 — 0.122; 0.056; -0.019 Liters — p=<0.001